Evaluation of a soybean product Fujiflavone P40 as an antiosteoporotic agent in rats

Phytotherapy Research

Volumn 17, Issue 2, 2003, Pages 112-119

  Hidaka, Saburo ^a   Okamoto, Yoshizo ^b   Miyazaki, Koji ^b   Uesugi, Takehiko ^c  

^a Fukuoka College of Health Sciences   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

^c WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

Author keywords

Bone mineral density; Fujiflavone P40 (soybean isoflavones); Ovariectomy; Peridontium; Serum lipids; Tibia

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COUMESTAN; DAIDZIN; ESTRADIOL; ESTROGEN; FUJIFLAVONE P40; GENISTIN; GLYCITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; KAMPO; LIGNAN DERIVATIVE; MACROGOL 400; PHYTOESTROGEN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PERIODONTAL LIGAMENT; RAT; UTERUS WEIGHT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; BONE DENSITY; CHOLESTEROL; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; ISOFLAVONES; MANDIBLE; MICROSCOPY, ELECTRON, SCANNING; OSTEOPOROSIS; OVARIECTOMY; PERIODONTAL LIGAMENT; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS; TIBIA; TRIGLYCERIDES;

GLYCINE MAX;

EID: 0037328735     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1047     Document Type: Article

References (34)

1. Arjmandi BH, Alekel L, Hollis BW et al. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167.
2. Chesnut CH, Baylink DJ. 1983. The role of anabolic steroids in the treatment of osteoporosis. Geriat Med Today 2: 21-29.
3. Clark RC, Tarttelin MF. 1982. Some effects of ovariectomy and estrogen replacement therapy. Lancet 11: 459-461.
4. Draper C, Edel MJ, Dick IM, Randal AG, Martin GB, Prince RL. 1997. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 127: 1795-1799.
5. Erikson EF, Colvard DS, Berg NJ et al. 1988. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84-86.
6. Fukuyama S, Tashjian Jr AH. 1989. Direct modulation by estradiol of the response of human bone cell (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology 124: 397-401.
7. Harrison E, Adjei A, Ameho C, Yamamoto S, Kono S. 1998. The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol 44: 257-268.
8. Hidaka S, Okamoto Y, Nakajima K, Suekawa M, Liu SY. 1997. Preventive effects of Chinese traditional (Kampo) medicines on experimental osteoporosis induced by ovariectomy in rats. Calcif Tissue Int 61: 239-246.
9. Hidaka S, Okamoto Y, Yamada Y, Kon Y, Kimura T. 1999. A Japanese herbal medicine, Chujo-to has a beneficial effect on the osteoporosis in rats. Phytother Res 13: 14-19.
10. Hidaka S, Okamoto Y, Yamada Y, Miyazaki K, Kimura T. 2000. Alterations in the periodontium after ovariectomy in rats: The effects of a Japanese herbal medicine, Chujo-to. Phytother Res 14: 527-533.
11. Ishida H, Uesugi T, Hirai K et al. 1998. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21: 62-66.
12. Kalu DN. 1991. The ovariectomized rat model for postmenopausal bone loss. Bone Miner 15: 175-192.
13. Kurzer MS, Xu X. 1997. Dietary phytoestrogens. Annu Rev Nutr 17: 353-381.
14. Lichtenstein AH. 1998. Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128: 1589-1592.
15. Liel Y, Kraus S, Levy J, Shany S. 1992. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). Endocrinology 130: 2597-2601.
16. Lundeen SG, Carver JM, McKean M-L, Winnerker RC. 1997. Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 138: 1552-1558.
17. Matsumoto C, Kushida K, Yamazaki K, Imose K, Inoue T. 1994. Metacarpal bone mass in normal and osteoporotic Japanese women using computed x-ray densitometry. Calcif Tissue Int 55: 324-329.
18. Mazzouli GF, Passeri M, Gennari C et al. 1986. Effect of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blinded clinical study. Calcif Tissue Int 38: 3-8.
19. Morris HA, Need AG, Horowitz M, O'Leughlin PD, Nordin BEC. 1991. Calcium adsorption in normal and osteoporotic postmenopausal women. Calcif Tissue Int 48: 240-243.
20. Nishikawa Y, Ikegami H, Sakata M et al. 1993. Ovariectomy increases the level of estrogen receptor mRNA and estrogen receptor binding sites in female rat adipose tissue. J Endocrinol Invest 16: 579-583.
21. Okubo K, Iijima M, Kobayashi Y, Kobayashi M, Uchida T, Kudou S. 1992. Components responsible for the undesirable taste of soybean seeds. Biosci Biotech Biochem 56: 99-103.
22. Omi A, Aoi S, Murata K, Ezawa I. 1994. Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. J Nutr Sci Vitaminol 40: 201-211.
23. Pacifici R, Rifas L, McCraken R et al. 1989. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc Natl Acad Sci USA 86: 2398-2402.
24. Price KR, Fenwick GR. 1985. Naturally occurring oestrogens in foods - A review. Food Add Cont 2: 73-106.
25. Riggs BL, Melton LJ III. 1995. Osteoporosis: Etiology, Diagnosis, and Management, 2nd edn. Lippincott-Raven: Philadelphia.
26. Roudebush RE, Magee DE, Benslay DN, Bendele AM, Bryan HU. 1993. Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rat. Calcif Tissue Int 52: 442-446.
27. Terasawa K. 1988. Kampo: Japanese-Oriental Medicine, K.K. Standard McIntyre: Tokyo.
28. Valette A, Meignen JM, Mercier L, Liehr JG, Boyer J. 1986. Effects of 2-fluoroestradiol on lipid metabolism in the ovariectomized rat. J Steroid Biochem 25: 575-578.
29. Van Lenten BJ, Melchior GW, Roheim PS. 1983. Lipoprotein metabolism in the ovariectomized rat. J Lipid Res 24: 1475-1484.
30. Watkins ML, Fizette N, Heimberg M. 1972. Sexual influences of hepatic secretion of triglyceride. Biochim Biophys Acta 280: 82-85.
31. Whalen JP, Krook L. 1996. Periodontal disease as the early manifestation of osteoporosis. Nutrition 12: 53-54.
32. Wronski TJ, Dann LM, Qi H, Yen C-F. 1993. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53: 210-216.
33. Xiu RJ. 1988. Microcirculation and traditional Chinese medicine. J Am Med Assoc 269: 1755-1757.
34. Yamazaki K, Shino A, Tsukuda R. 1986. Effect of ipriflavone on osteoporosis induced by ovariectomy in rats. Jpn J Bone Metab 3: 205-210.